Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$479.6K

Rothblatt Martine A Chairperson & CEO

Transaction date Jul 1, 2026
Public filing date Jul 2, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$547.15 Jul 1, 2026
First close after public filing
$547.25 Jul 6, 2026
30-day return after filing
-5.65% Through Aug 3, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
880 shares @ $545
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001106578-26-000090
Filing cohort

Transactions in this filing

Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$6.45M
Buys / sales
0 / 11
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Exercise Jul 1, 2026 $1.29M
United Therapeutics Corp UTHR Sale Jul 1, 2026 $217.72K
United Therapeutics Corp UTHR Sale Jul 1, 2026 $440.97K
United Therapeutics Corp UTHR Sale Jul 1, 2026 $822.85K
United Therapeutics Corp UTHR Sale Jul 1, 2026 $418.13K
United Therapeutics Corp UTHR Sale Jul 1, 2026 $477.09K
United Therapeutics Corp UTHR Sale Jul 1, 2026 $282.44K
United Therapeutics Corp UTHR Current Sale Jul 1, 2026 $479.6K
United Therapeutics Corp UTHR Sale Jul 1, 2026 $614.22K
United Therapeutics Corp UTHR Sale Jul 1, 2026 $530.43K
United Therapeutics Corp UTHR Sale Jul 1, 2026 $669.37K
United Therapeutics Corp UTHR Sale Jul 1, 2026 $211.97K
United Therapeutics Corp UTHR Exercise Jul 1, 2026 $0